BPC-157 / KPV

BPC-157 / KPV is a research blend in the Healing & Recovery category that combines two short peptide sequences studied in the preclinical literature. BPC-157 is a synthetic pentadecapeptide derived from a partial sequence of a protein identified in gastric secretions, while KPV is a tripeptide (lysine-proline-valine) corresponding to the C-terminal fragment of alpha-melanocyte-stimulating hormone (alpha-MSH). Combined as a blend, the two sequences are of interest to investigators examining tissue-repair signaling and inflammatory-pathway modulation in parallel. This material is supplied strictly for laboratory research and professional reference use. It is not approved by the FDA for therapeutic use, and nothing here constitutes a therapeutic, diagnostic, or treatment claim. Any effects discussed in the scientific literature are observations from research settings, and individual results vary.

• Investigated in preclinical literature in the context of soft-tissue, tendon, and musculoskeletal repair signaling (research context only; individual results vary)
• Studied in research models in relation to gastrointestinal mucosal integrity and epithelial barrier function (individual results vary)
• Reported in research as being of interest for modulation of local inflammatory pathways, including those associated with alpha-MSH / melanocortin signaling (individual results vary)
• Examined in laboratory settings in connection with angiogenesis and microvascular response relevant to wound-healing research (individual results vary)
• Of interest in research exploring combined repair- and inflammation-related signaling within a single blend (outcomes vary; not a therapeutic claim)

Reference handling information only. Typically supplied as a lyophilized (freeze-dried) powder. For research handling, lyophilized peptide is generally reconstituted with bacteriostatic or sterile water added slowly against the vial wall and gently swirled rather than shaken until fully dissolved. Unreconstituted vials are commonly stored frozen and protected from light and moisture; once reconstituted, material is typically kept refrigerated, protected from light, and used within a limited window per the laboratory's own stability practices. Avoid repeated freeze-thaw cycles and keep away from heat. All reconstitution volumes, concentrations, clinical protocols, and any use decisions are determined solely by the licensed ordering provider at their professional discretion; this is reference information for research and professional use only and is not medical advice.

A per-lot Certificate of Analysis, HPLC purity profile, and mass-spectrometry verification are available on request for this product. Ask your account manager for the current lot documentation.

In the published research literature, BPC-157 is described as interacting with cytoprotective and angiogenic signaling, with proposed involvement of nitric oxide pathways, growth-factor receptor activity (including VEGF-related signaling), and modulation of focal adhesion and extracellular-matrix dynamics that are studied in the context of tissue repair. KPV, as a C-terminal alpha-MSH fragment, has been investigated for anti-inflammatory activity thought to act on intracellular signaling that dampens pro-inflammatory transcription-factor activity such as NF-kB. As a blend, the two sequences are studied for potentially complementary mechanisms, one oriented toward repair and vascular signaling, the other toward inflammatory modulation. These mechanisms remain under investigation, are not established as therapeutic effects, and individual results vary.